• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind

cafead

Administrator
Staff member
  • cafead   Sep 03, 2024 at 11:22: AM
via As Orgenesis works to decentralize and democratize CAR-T therapies, its candidate therapy has shown complete response rates of more than 80% in a clinical study in China.

article source
 

<